Square Pharma Ltd
SQUARE PHARMACEUTICALS LIMITED
Mission
Our Mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large.
Vision
We view business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization.
Objectives
Our objectives are to conduct transparent business operation based on market mechanism within the legal & social framework with aims to attain the mission reflected by our vision.
Global Pharmaceutical Industry Overview
T
he pharmaceutical industry of the world develops and markets medicines prescribed for patients by medical practitioners. The U.S., U.K and European pharmaceutical companies are the major ones of the industry. The total number of major pharmaceutical companies worldwide is estimated to be about 50.
The global pharmaceutical industry recorded annual revenue of $830 billion in 2010 with a healthy growth rate of around 5 to 6 percent. While the pharmaceutical industry in regions like Latin America, Europe and Japan are growing at a steady rate (which is more are less equal to that of the overall industry), the developing regions like China and India are recording corresponding growth in double figures. Industry analysts’ predict that the pharmaceutical market would reach $1.1 trillion by2015 with the average growth rate of around 7 percent.
Bangladesh’s Pharmaceutical Industry Overview
T
he Bangladesh pharmaceutical market in 2004 stood at approximately US $ 560 million, which was very small when compared to the population base of the country, which currently stood at about 140 million. To put this number on a proper perspective, the total global pharmaceutical sale in 2004 was $430 billion. This is expected to
Mission
Our Mission is to produce and provide quality & innovative healthcare relief for people, maintain stringently ethical standard in business operation also ensuring benefit to the shareholders, stakeholders and the society at large.
Vision
We view business as a means to the material and social wellbeing of the investors, employees and the society at large, leading to accretion of wealth through financial and moral gains as a part of the process of the human civilization.
Objectives
Our objectives are to conduct transparent business operation based on market mechanism within the legal & social framework with aims to attain the mission reflected by our vision.
Global Pharmaceutical Industry Overview
T
he pharmaceutical industry of the world develops and markets medicines prescribed for patients by medical practitioners. The U.S., U.K and European pharmaceutical companies are the major ones of the industry. The total number of major pharmaceutical companies worldwide is estimated to be about 50.
The global pharmaceutical industry recorded annual revenue of $830 billion in 2010 with a healthy growth rate of around 5 to 6 percent. While the pharmaceutical industry in regions like Latin America, Europe and Japan are growing at a steady rate (which is more are less equal to that of the overall industry), the developing regions like China and India are recording corresponding growth in double figures. Industry analysts’ predict that the pharmaceutical market would reach $1.1 trillion by2015 with the average growth rate of around 7 percent.
Bangladesh’s Pharmaceutical Industry Overview
T
he Bangladesh pharmaceutical market in 2004 stood at approximately US $ 560 million, which was very small when compared to the population base of the country, which currently stood at about 140 million. To put this number on a proper perspective, the total global pharmaceutical sale in 2004 was $430 billion. This is expected to
References: Chakraborty, K & Sur, D (2011). “Evaluating relationship of working capital and profitability: a study of select multinational companies in the Indian pharmaceutical sector”, The IUP Journal of Management Research, Vol. X(2), pp. 7-8. Hall C (2002), ‘Total’ working capital management’, AFP Exchange, Vol. 22(6), pp. 26- 32. Harris A (2005), “Working capital management: difficult, but rewarding”, Financial Executive, Vol. 21, No. 4, pp. 52-53. Mallik A K, Sur D and Rakshit D (2005), “Working capital and profitability: a study on their relationship with reference to selected companies in Indian pharmaceutical industry”, GITAM Journal of Management, Vol. 3, No. 2, pp. 51-62. Mathuva D.M. (2009), “The Influence of Working Capital Management Components on Corporate Profitability: A Survey on Kenyan Listed Firms”, Research Journal of Business Management, Retrieved From www.docsdrive.com/pdfs/academicjournals/rjbm/0000/15988-15988.pdf Shin, H H and Soenen, L. (1998), Efficiency of Working Capital and Corporate Profitability, Financial Practice and Education, Vol. 8, No. 2, pp 37-45. Smith M B (1997), “Measuring associations between working capital and return on investment”, South African Journal of Business Management, Vol. 28, No. 1, pp. 1-4. Soenen L A (1993), “Cash conversion cycle and corporate profitability”, Journal of Cash Management, Vol. 13, No. 4, pp. 53-58.